CELLFORCURE
CellforCure is a key industrial and innovative player in the field of advanced therapy medicinal products.
CELLFORCURE
Social Links:
Industry:
Biotechnology Health Care
Founded:
2010-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.cellforcure.com
Total Employee:
101+
Status:
Active
Contact:
33 (0) 1 69 82 17 21
Email Addresses:
[email protected]
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Cloudflare Hosting Proofpoint CodeTwo Akamai DNS
Similar Organizations
Acthera Therapeutics
Acthera Therapeutics is developing an innovative nanotechnology-based platform for the controlled and targeted drug delivery
Merck
Merck is a pharmaceutical and chemical enterprise that develops prescription drugs and over-the-counter products.
Current Employees Featured
Official Site Inspections
http://www.cellforcure.com
- Host name: 104.18.0.16
- IP address: 104.18.0.16
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "CellforCure"
Home | Cell4Cure AB
Feb 26, 2025 Cell4Cure AB, a cell therapy company for development of treatments for the inducing of immune tolerance. The proprietary technology platform is based on dendritic cells …See details»
Novartis announces offer to acquire CellforCure to expand …
Dec 20, 2018 Established as a pharmaceutical company since 2013, CellforCure operates a Contract Development and Manufacturing Organization. The company obtained two Good …See details»
CELLforCURE by Seqens - LinkedIn
CELLforCURE by Seqens | 2,198 followers on LinkedIn. Trustworthy development and commercial manufacturing of CELL&GENE therapies | On december 1st 2023, Seqens …See details»
CellforCure - Crunchbase Company Profile & Funding
Organization. CellforCure . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. CellforCure is a key industrial and innovative player in the …See details»
Seqens confirms the acquisition of CELLforCURE - SEQENS
Dec 1, 2023 SEQENS confirms the acquisition of the CELLforCURE site at Les Ulis (91) from NOVARTIS as of December 1st, and presents its transformation project to make it a leader in …See details»
CellforCure Company Profile - Office Locations, Competitors
CellforCure Summary. Company Summary. Overview. CellforCure is a pharmaceutical company specializing in cell and gene therapy drugs. It offers an industrial platform for drug …See details»
CELLforCURE - Overview, News & Similar companies - ZoomInfo
Dec 20, 2018 Who is CELLforCURE. CELLforCURE is a pharmaceutical company, and has been a pharmaceutical establishment since 2013, acting as a CDMO (Contract Development …See details»
CELLforCURE - Products, Competitors, Financials, Employees ...
May 10, 2021 CELLforCURE is a contract development and manufacturing organization providing large-scale GMP and cGMP production services for both clinical and commercial …See details»
Cellforcure: Revenue, Worth, Valuation & Competitors 2025
About Cellforcure. Cellforcure is a Biotech related company founded in 2010 and based in France with 127 employees an estimated revenue of $19.7M, and. It has 10 competitors including …See details»
CELLforCURE 2025 Company Profile: Valuation, Investors
When was CELLforCURE founded? CELLforCURE was founded in 2010. Where is CELLforCURE headquartered? CELLforCURE is headquartered in Les Ulis, France. What is …See details»
Cell for cure - ESGCT Congress
CELLforCURE by Seqens is currently one of the very few companies worldwide experienced with manufacturing cell and gene therapy drugs. With more than 10 000 m2 of building surface and …See details»
Novartis sells France CGT biz to Seqens - bioprocessintl.com
Dec 19, 2023 Seqens has acquired Novartis’ CGT CDMO CELLforCURE and its manufacturing site located in Les Ulis, about 23km from Paris. With this purchase, French contract …See details»
Home - CELL & GENE
CELLforCURE by SEQENS stands as a leading EMA-authorized CDMO, dedicated to advancing Cell & Gene Therapies from concept to commercialization. CELLforCURE by SEQENS quality …See details»
CellforCure S.A.S.U - CMOCRO - Domain Name
CellforCure operates as a pharmaceutical company. The Company develops and manufactures cell and gene therapy products. CellforCure acts as contract development and manufacturing …See details»
Company profile | CELLforCURE | My Biologics Partner
About us. CELLforCURE is currently one of the very few companies worldwide experienced with manufacturing cell and gene therapy drugs that have been administered to a large numbers of …See details»
Novartis Announces Offer to Acquire Cellforcure
Dec 20, 2018 Established as a pharmaceutical company since 2013, CellforCure operates a Contract Development and Manufacturing Organization. The company obtained two Good …See details»
Novartis To Acquire CDMO CellforCure for Cell and Gene Therapy ...
Jan 11, 2019 Novartis has made an offer to acquire CellforCure, a contract development and manufacturing organization (CDMO) producing cell and gene therapies in Europe, from LFB, a …See details»
Novartis, CELLforCURE Partner to Manufacture CAR-T Therapies
Jul 18, 2018 Novartis announced on July 10, 2018, that it had entered into an agreement with contract development and manufacturing organization (CDMO), CELLforCURE, a company of …See details»
Smart Immune and CELLforCURE by SEQENS Partner to …
Smart Immune, a clinical-stage biotechnology company, and CELLforCURE by SEQENS, a Contract Development and Manufacturing Organization (CDMO) for Advanced Therapy …See details»
Smart Immune and CELLforCURE by SEQENS partner to …
Dec 3, 2024 The choice of CELLforCURE, with its established track record in commercial cell therapy manufacturing, aligns with Smart Immune’s commitment to maintaining production …See details»